Crossmark

Is isolated aortic valve replacement sufficient to treat concomitant moderate functional mitral regurgitation? A propensity-matched analysis

Crossref DOI link: https://doi.org/10.1186/s13019-018-0760-3

Published Online: 2018-06-19

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sorabella, Robert A.

Olds, Anna

Yerebakan, Halit

Hassan, Dua

Borger, Michael A.

Argenziano, Michael

Smith, Craig R.

George, Isaac https://orcid.org/0000-0001-7770-4450
License Information

Text and Data Mining valid from 2018-06-19
More Information

Article History

Received: 29 March 2018

Accepted: 7 June 2018

First Online: 19 June 2018

Ethics approval and consent to participate

: The study was approved by the Columbia University Institutional Review Board and need for individual patient consent was waived.

: Not applicable.

: Isaac George is a consultant for Medtronic and for Edwards Lifesciences Inc. Craig Smith is the Surgical Principal Investigator of the PARTNER and PARTNER II Trials, for which travel and customary expenses associated with Trial management are reimbursed by the sponsor, Edwards LifeSciences.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.